Amphastar P (AMPH)

Exchange
NASDAQ
Symbol
AMPH
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
Country
USA

Stock price

At close: December 20, 2024

  • Open
    39.31
  • High
    40.74
  • Low
    38.96
  • Close
    39.14
  • Volume
    2,484,940

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
2.77
Receivables turnover
5.61
Payables turnover
11.53
Working capital turnover
2.44
Days of inventory on hand (DOH)
131.72
Days of sales outstanding (DSO)
65.11
Number of days of payables
31.66
Fixed asset turnover
2.28
Total asset turnover
0.43
 Liquidity ratios
Current ratio
2.17
Quick ratio
1.65
Cash ratio
1.14
Cash conversion cycle
165.16
 Solvency ratios
Debt-to-assets ratio
0.40
Debt-to-capital ratio
0.49
Debt-to-equity ratio
0.94
Financial leverage ratio
2.37
Interest coverage
7.24
 Profitability ratios
Gross profit margin
54.49%
Operating profit margin
30.57%
Pretax margin
26.28%
Net profit margin
21.34%
Operating return on assets (Operating ROA)
13.02%
Return on assets (ROA)
9.09%
Return on total capital
15.82%
Return on equity (ROE)
21.51%